Monday, April 25, 2022

Illumina In Deal With German Hospital For Genetic Disease Diagnosis

San Diego-based lifesciences equipment maker Illumina said today that it has inked a deal with a German hospital, to offer up whole-genome sequencing for critically ill children suspected of having a genetic or rare disease. According to Illumina, the deal is with Germany's Hannover Medical School (Medizinische Hochschule Hannover (MHH)). The company said its tools will be used to evaluate the diagnostic efficacy of whole genome sequencing for pediastric precision medicine.